journal article·2025-06Open access

Hydrogel‐Transformable Probiotic Powder for Targeted Eradication of Helicobacter pylori with Enhanced Gastric Mucosal Repair and Microbiota Preservation

Yongkang Lai, Hanchun Shen, Shige Wang, Yongliang Ouyang, Xinyuan Zhang, Bin Hu, Xiaoyi Zhang, Guisheng Li, Lizhi Xu, Jiulong Zhao

Advanced Science· Volume 12· Issue 23

Abstract

Abstract Lactobacillus reuteri ( L. reuteri ) therapies represent a potentially effective approach to eradicating Helicobacter pylori (H. pylori) . However, the difficulty in bacterial viability preservation and harsh gastric environment compromises the survival and on‐target delivery of L. reuteri . This study presents a novel bacterium‐mediated bacterial elimination strategy using an edible L. reuteri @HTP probiotic powder for targeted bacterial elimination. The probiotic powder is obtained by grinding a lyophilized hydrogel composed of L. reuteri , hyaluronic acid (HA), tannic acid (TA), and polyvinyl alcohol (PVA). Upon contact with water, the powder quickly transforms into a hydrogel, enhancing L. reuteri ’s survival in the harsh gastric environment and ensuring selective release at H. pylori ‐infected inflammatory sites. L. reuteri targets and reduces H. pylori colonization while secreting reuterin to eliminate the bacteria. Additionally, TA's antioxidant properties help alleviate inflammation, and HA supports gastric mucosal repair. L. reuteri @HTP powder preserves the integrity of the gut microbiota, facilitating the restoration of a healthy microbiome. In particular, the probiotic powder remains stable at room temperature for at least six months, providing a promising alternative to traditional antibiotics for H. pylori treatment. This strategy combines targeted eradication, mucosal healing, and microbiome restoration, offering a new approach to treating gastric infections.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Helicobacter pylori-related gastroenterology studies · Microbial Metabolites in Food Biotechnology · Gastric Cancer Management and Outcomes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Gastroenterology, Shanghai Institute of Pancreatic Diseases, Changhai Hospital; National Key Laboratory of Immunity and Inflammation Naval Medical University Shanghai 200433 P. R. China

School of Materials and Chemistry University of Shanghai for Science and Technology Shanghai 200093 P. R. China

Department of Mechanical Engineering The University of Hong Kong Hong Kong SAR 999077 P. R. China

Advanced Biomedical Instrumentation Centre Hong Kong Science Park Shatin, New Territories Hong Kong SAR 999077 P. R. China

Materials Innovation Institute for Life Sciences and Energy (MILES) The University of Hong Kong Shenzhen Institute of Research and Innovation (HKU‐SIRI) Shenzhen 518057 P. R. China

References (57)

Show source-provided references
1. 10.1016/S2468-1253(23)00070-510.1016/S2468-1253(23)00070-5 ↗
2. 10.1136/gutjnl-2022-32774510.1136/gutjnl-2022-327745 ↗
3. 10.1136/gutjnl-2018-31755610.1136/gutjnl-2018-317556 ↗
4. 10.1136/gutjnl-2021-32563010.1136/gutjnl-2021-325630 ↗
5. 10.1111/jgh.1494710.1111/jgh.14947 ↗
6. 10.1136/gutjnl-2022-32896510.1136/gutjnl-2022-328965 ↗
7. 10.1136/gutjnl-2015-30925210.1136/gutjnl-2015-309252 ↗
8. 10.1136/gutjnl-2021-32617010.1136/gutjnl-2021-326170 ↗
9. 10.1080/19490976.2022.212074710.1080/19490976.2022.2120747 ↗
10. 10.1136/gutjnl-2020-32236810.1136/gutjnl-2020-322368 ↗
11. 10.1039/D3CS00369H10.1039/D3CS00369H ↗
12. 10.1002/adma.20210666910.1002/adma.202106669 ↗
13. 10.1038/s41564-022-01089-w10.1038/s41564-022-01089-w ↗
14. 10.1186/s13059-021-02344-910.1186/s13059-021-02344-9 ↗
15. 10.1080/19490976.2020.183133910.1080/19490976.2020.1831339 ↗
16. 10.1080/19490976.2020.179538810.1080/19490976.2020.1795388 ↗
17. 10.1073/pnas.100009910710.1073/pnas.1000099107 ↗
18. 10.1007/s12602-014-9181-310.1007/s12602-014-9181-3 ↗
19. 10.3389/fcimb.2022.104207010.3389/fcimb.2022.1042070 ↗
20. 10.1111/hel.1285610.1111/hel.12856 ↗
21. 10.3390/nu1414278910.3390/nu14142789 ↗
22. 10.1111/hel.1301710.1111/hel.13017 ↗
23. 10.1002/adma.20210024110.1002/adma.202100241 ↗
24. 10.1038/s41563-023-01472-w10.1038/s41563-023-01472-w ↗
25. 10.1126/science.adl110210.1126/science.adl1102 ↗
26. 10.1016/j.apsb.2024.03.01410.1016/j.apsb.2024.03.014 ↗
27. 10.1002/adma.20210573810.1002/adma.202105738 ↗
28. 10.1039/D4MH00289J10.1039/D4MH00289J ↗
29. 10.1038/s41563-024-01811-510.1038/s41563-024-01811-5 ↗
30. 10.1016/j.jare.2013.07.00610.1016/j.jare.2013.07.006 ↗
31. 10.1039/D0FO01394C10.1039/D0FO01394C ↗
32. 10.1111/1541-4337.1328710.1111/1541-4337.13287 ↗
33. 10.1002/smll.20190212310.1002/smll.201902123 ↗
34. 10.1002/advs.20210254510.1002/advs.202102545 ↗
35. 10.1016/j.biomaterials.2023.12234610.1016/j.biomaterials.2023.122346 ↗
36. 10.3390/ijms2211562410.3390/ijms22115624 ↗
37. 10.1016/j.actbio.2023.01.04510.1016/j.actbio.2023.01.045 ↗
38. 10.1002/adfm.20210968710.1002/adfm.202109687 ↗
39. 10.1038/ncomms729510.1038/ncomms7295 ↗
40. 10.1016/j.redox.2018.02.00310.1016/j.redox.2018.02.003 ↗
41. 10.3390/microorganisms1003052210.3390/microorganisms10030522 ↗
42. 10.1099/mic.0.035642-010.1099/mic.0.035642-0 ↗
43. 10.3390/vetsci910052710.3390/vetsci9100527 ↗
44. 10.1016/j.bioactmat.2022.05.01710.1016/j.bioactmat.2022.05.017 ↗
45. 10.1111/hel.1294410.1111/hel.12944 ↗
46. 10.1186/s13045-020-00936-910.1186/s13045-020-00936-9 ↗
47. 10.1186/s12967-024-04913-510.1186/s12967-024-04913-5 ↗
48. 10.1016/j.tim.2008.05.00510.1016/j.tim.2008.05.005 ↗
49. 10.1053/j.gastro.2015.09.00410.1053/j.gastro.2015.09.004 ↗
50. 10.1016/j.placenta.2013.12.00910.1016/j.placenta.2013.12.009 ↗
51. 10.1007/s12032-014-0433-610.1007/s12032-014-0433-6 ↗
52. 10.1016/j.ajpath.2017.02.00610.1016/j.ajpath.2017.02.006 ↗
53. 10.1080/19490976.2023.218503410.1080/19490976.2023.2185034 ↗
54. 10.7150/thno.6646410.7150/thno.66464 ↗
55. 10.1186/s40168-017-0242-110.1186/s40168-017-0242-1 ↗
56. 10.1038/s41392-022-00974-410.1038/s41392-022-00974-4 ↗
57. 10.3389/fmicb.2018.0075710.3389/fmicb.2018.00757 ↗